Who invested in Repertoire Immune Medicines?
Repertoire Immune Medicines's investors include SoftBank, SoftBank Vision Fund, Invus and Flagship Pioneering.
Who invested in Repertoire Immune Medicines
Funding summaryUpdated 26 Oct 2026
$189Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $189MApr 2021
- Investors
- 4
The rounds
- Apr 2021
Founders and team
From Repertoire Immune Medicines's own website: 2 on the team.
- Regina SherwoodVice President of Human Resources
- Suzanne GrecoSenior Vice President, Finance
Everyone who backed them
SoftBank Vision FundVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Repertoire Immune Medicines
How much has Repertoire Immune Medicines raised?
Repertoire Immune Medicines has raised $189M across 1 round since 2021.
When did Repertoire Immune Medicines last raise?
Repertoire Immune Medicines's most recent round was a Series B of $189M in Apr 2021.
What was Repertoire Immune Medicines's biggest round?
Its most recent round, $189M in Apr 2021, is also its largest on record.
Who backed Repertoire Immune Medicines first?
Repertoire Immune Medicines's first round on record, in Apr 2021, was backed by SoftBank, SoftBank Vision Fund and Invus and 1 others.
What stage is Repertoire Immune Medicines at?
Repertoire Immune Medicines's latest named round is a Series B, in Apr 2021.
Companies like Repertoire Immune Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.